Skip to main content
OpenTrials

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,008 public trials 572 recruiting studies
Refine in advanced search Browse all conditions

Paraproteinemias trial results

Completed

SAR650984, Pomalidomide and Dexamethasone in Combination in RRMM Patients

NCT02283775

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Investigational Site Number 840001 Scottsdale, Arizona, United States
  • Investigational Site Number 840006 Duarte, California, United States
  • Investigational Site Number 840018 New Haven, Connecticut, United States
  • Investigational Site Number 840011 Decatur, Illinois, United States
View all 13 locations
View Trial Details
Completed

BI-1206 and an Anti-CD20 Antibody in Patients With CD32b Positive B-cell Lymphoma or Leukaemia

NCT02933320

Conditions
B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +22 more
Locations
  • Leicester Royal Infirmary Leicester, England, United Kingdom
  • Christie Hospital Manchester, England, United Kingdom
  • Oxford Cancer and Haematology Centre, Churchill Hospital Oxford, England, United Kingdom
  • Derriford Hospital Plymouth, United Kingdom
View Trial Details
Completed

A Study of Elotuzumab in Combination With Pomalidomide and Low Dose Dexamethasone and Elotuzumab in Combination With Nivolumab in Patients With Multiple Myeloma Relapsed or Refractory to Prior Treatment With Lenalidomide.

NCT02612779

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Southern Cancer Center Mobile, Alabama, United States
  • Sansum Clinic - USOR Santa Barbara, California, United States
  • Colorado Blood Cancer Institute - PPDS Denver, Colorado, United States
  • Rocky Mountain Cancer Centers (Williams) - USOR Denver, Colorado, United States
View all 22 locations
View Trial Details
Completed

Ipilimumab or Nivolumab in Treating Patients With Relapsed Hematologic Malignancies After Donor Stem Cell Transplant

NCT01822509

Conditions
Allogeneic Hematopoietic Stem Cell Transplant Recipient, Blood Protein Disorders, Bone Marrow Diseases, +44 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • City of Hope South Pasadena South Pasadena, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
View all 13 locations
View Trial Details
Completed

Randomised Trial in Waldenstrom's Macroglobulinaemia

NCT01592981

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Basingstoke & North Hampshire Hospital Basingstoke, United Kingdom
  • Royal United Hospital Bath, United Kingdom
  • Birmingham Heartlands Hospital Birmingham, United Kingdom
  • City Hospital Birmingham, United Kingdom
View all 30 locations
View Trial Details

Related conditions